Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids

(2014) Radha Ramesh et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response

(2013) Chiara Camisaschi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation

(2013) Lynae M. Brayboy et al.   FERTILITY AND STERILITY

Human CD4+CD25+ Regulatory T Cells Are Sensitive to Low Dose Cyclophosphamide: Implications for the Immune Response

(2013) Daniel Heylmann et al.   PLoS One

Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

(2013) C. G. Kanakry et al.   Science Translational Medicine

Cyclophosphamide metabolite inducing apoptosis in RLS mouse lymphosarcoma cells is a substrate for P-glycoprotein

(2012) O. A. Patutina et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

(2011) Vincenzo Cerullo et al.   MOLECULAR THERAPY

Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study

(2011) Daniela Caronia et al.   PLoS One

The siRNA targeted to mdr1b and mdr1a mRNAs in vivosensitizes murine lymphosarcoma to chemotherapy

(2010) Olga A Patutina et al.   BMC CANCER

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

(2010) J Bray et al.   BRITISH JOURNAL OF CANCER

Selective Depletion of CD4+CD25+Foxp3+Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP Levels

(2010) Jie Zhao et al.   CANCER RESEARCH

Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma

(2009) Miki Tongu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A Distinct Subset of Self-Renewing Human Memory CD8+ T Cells Survives Cytotoxic Chemotherapy

(2009) Cameron J. Turtle et al.   IMMUNITY

Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model

(2008) A. P. Castano et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA